Drug trial aims to block inflammation, stop cancer before it starts in Ex-Smokers
NCT ID NCT06038526
Summary
This study is testing whether a drug called canakinumab can help prevent lung cancer in former heavy smokers. Researchers are giving the drug to 41 participants to see if it reduces inflammation in the lungs, which is linked to cancer development. The main goal is to see if blocking a specific inflammatory protein changes biological markers in samples taken from the nose, mouth, and blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
Conditions
Explore the condition pages connected to this study.